- Home
- GAM vs TNDM Comparison
GAM vs TNDM Comparison
Compare GAM & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAM
- TNDM
- Stock Information
- Founded
- GAM 1927
- TNDM 2006
- Country
- GAM United States
- TNDM United States
- Employees
- GAM N/A
- TNDM N/A
- Industry
- GAM Investment Managers
- TNDM Medical/Dental Instruments
- Sector
- GAM Finance
- TNDM Health Care
- Exchange
- GAM Nasdaq
- TNDM Nasdaq
- Market Cap
- GAM 1.3B
- TNDM 1.1B
- IPO Year
- GAM N/A
- TNDM 2013
- Fundamental
- Price
- GAM $56.90
- TNDM $15.59
- Analyst Decision
- GAM
- TNDM Buy
- Analyst Count
- GAM 0
- TNDM 13
- Target Price
- GAM N/A
- TNDM $32.15
- AVG Volume (30 Days)
- GAM 20.1K
- TNDM 1.6M
- Earning Date
- GAM 01-01-0001
- TNDM 08-06-2025
- Dividend Yield
- GAM 5.74%
- TNDM N/A
- EPS Growth
- GAM N/A
- TNDM N/A
- EPS
- GAM 11.67
- TNDM N/A
- Revenue
- GAM N/A
- TNDM $982,951,000.00
- Revenue This Year
- GAM N/A
- TNDM $8.91
- Revenue Next Year
- GAM N/A
- TNDM $11.04
- P/E Ratio
- GAM $3.95
- TNDM N/A
- Revenue Growth
- GAM N/A
- TNDM 27.65
- 52 Week Low
- GAM $37.32
- TNDM $15.17
- 52 Week High
- GAM $46.48
- TNDM $48.24
- Technical
- Relative Strength Index (RSI)
- GAM 76.57
- TNDM 27.20
- Support Level
- GAM $56.23
- TNDM $15.17
- Resistance Level
- GAM $57.54
- TNDM $17.12
- Average True Range (ATR)
- GAM 0.72
- TNDM 0.99
- MACD
- GAM 0.08
- TNDM -0.31
- Stochastic Oscillator
- GAM 92.31
- TNDM 6.99
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.